HB
Hemrajbhai Babubhai Anghan
About Hemrajbhai Babubhai Anghan
Data last updated:
Hemrajbhai Babubhai Anghan is a Director at Edges Medicare Private Limited (since 2020) and Director at Omicron Pharma Private Limited (since 2022). The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹8.44 Cr; the largest is Edges Medicare Private Limited at ₹6.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Oct 2020 | 2020 | ₹6.34 Cr (FY 2025) | Active | |
| Director | 07 Jun 2022 | 2022 | ₹2.10 Cr (FY 2025) | Active |
Board colleagues of Hemrajbhai Babubhai Anghan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhaykumar Ashokbhai Tandel | 08906938 | Edges Medicare Private Limited , Omicron Pharma Private Limited | Director |
| Dharmesh Rameshbhai Kathiriya | 08906937 | Edges Medicare Private Limited , Omicron Pharma Private Limited | Director |
| Hiteshkumar Madhubhai Paneliya | 08911160 | Edges Medicare Private Limited , Omicron Pharma Private Limited | Director |
| Monikaben Jatinbhai Patel | 06573822 | Edges Medicare Private Limited , Omicron Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemrajbhai Babubhai Anghan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemrajbhai Babubhai Anghan
Hemrajbhai Babubhai Anghan currently holds 2 directorships: Edges Medicare Private Limited (Director, since 09 Oct 2020, revenue ₹6.34 Cr (FY 2025)); Omicron Pharma Private Limited (Director, since 07 Jun 2022, revenue ₹2.10 Cr (FY 2025)).
Hemrajbhai Babubhai Anghan was first appointed on 09 Oct 2020 as Director at Edges Medicare Private Limited. The most recent appointment on record is 07 Jun 2022 at Omicron Pharma Private Limited.
The 2 current companies of Hemrajbhai Babubhai Anghan that report revenue have a combined latest revenue of ₹8.44 Cr: Edges Medicare Private Limited ₹6.34 Cr (FY 2025); Omicron Pharma Private Limited ₹2.10 Cr (FY 2025).
The current boards of Hemrajbhai Babubhai Anghan's companies include Abhaykumar Ashokbhai Tandel (Edges Medicare Private Limited), Dharmesh Rameshbhai Kathiriya (Edges Medicare Private Limited), Hiteshkumar Madhubhai Paneliya (Edges Medicare Private Limited), Monikaben Jatinbhai Patel (Edges Medicare Private Limited).